The delivery of drugs to the eye can be prolonged via a gelling hypotonic solution that forms a clear thin layer on the eye’s surface.
References
Sleath, B. et al. Ophthalmology 118, 2398–2402 (2011).
Schwartz, G. F. & Quigley, H. A. Surv. Ophthalmol. 53, S57–S68 (2008).
Seah, I. et al. Eye 34, 1341–1356 (2020).
Al-Kinani, A. A. et al. Adv. Drug Deliv. Rev. 126, 113–126 (2018).
Kim, Y. C. et al. Nat Biomed Eng. https://doi.org/10.1038/s41551-020-00606-8 (2020).
Russo, E. & Villa, C. Pharmaceutics 11, 671 (2019).
Tsujinaka, H. et al. Nat Commun. 11, 694 (2020).
Cabrera, F. J., Wang, D. C., Reddy, K., Acharya, G. & Shin, C. S. Drug Discov. Today 24, 1679–1684 (2019).
Liu, C. H., Wang, Z., Sun, Y. & Chen, J. FASEB J. 31, 4665–4681 (2017).
Lau, P. E., Jenkins, K. S. & Layton, C. J. J. Ophthalmol. 2018, 8567912 (2018).
Kompella, U. B., Hartman, R. R. & Patil, M. A. Prog. Retin. Eye Res. https://doi.org/10.1016/j.preteyeres.2020.100901 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Seah, I., Loh, X.J. & Su, X. A topical gel for extended ocular drug release. Nat Biomed Eng 4, 1024–1025 (2020). https://doi.org/10.1038/s41551-020-00645-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-020-00645-1
- Springer Nature Limited